Assay Detail
Functional
CHEMBL5541350
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiproliferative activity against human ICC13-7 cells expressing FGFR2 V565F mutant assessed as inhibition of cell growth incubated for 10 days by Cell-titer glo assay
7
Total Activities
7
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | ICC13-7 |
| Confidence | 0 — Uncurated / Unknown |
| Curated By | Autocuration |
Publication
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 7 | 8.28 | 9.05 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5571671 | — | — | 1 | 9.05 |
| CHEMBL5589734 | — | — | 1 | 8.85 |
| CHEMBL5314537 | RESIGRATINIB | 2.0 | 1 | 8.37 |
| CHEMBL3701238 | FUTIBATINIB | 4.0 | 1 | 6.84 |
| CHEMBL3545376 | ERDAFITINIB | 4.0 | 1 | - |
| CHEMBL4297522 | PEMIGATINIB | 4.0 | 1 | - |
| CHEMBL1852688 | INFIGRATINIB | 4.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5571671 | — | IC50 | = | 0.9 | nM | 9.05 |
| CHEMBL5589734 | — | IC50 | = | 1.4 | nM | 8.85 |
| CHEMBL5314537 | RESIGRATINIB | IC50 | = | 4.3 | nM | 8.37 |
| CHEMBL3701238 | FUTIBATINIB | IC50 | = | 143.0 | nM | 6.84 |
| CHEMBL3545376 | ERDAFITINIB | IC50 | > | 2800.0 | nM | - |
| CHEMBL4297522 | PEMIGATINIB | IC50 | > | 2350.0 | nM | - |
| CHEMBL1852688 | INFIGRATINIB | IC50 | > | 1890.0 | nM | - |